Antitrypanosomal activity of 1, 2-dihydroquinolin-6-ols and their ester derivatives

J Fotie, M Kaiser, DA Delfín, J Manley… - Journal of medicinal …, 2010 - ACS Publications
The current chemotherapy for second stage human African trypanosomiasis is
unsatisfactory. A synthetic optimization study based on the lead antitrypanosomal compound …
被引用次数：99 相关文章

[引用][C] Antitrypanosomal Activity of 1, 2-Dihydroquinolin-6-ols and Their Ester Derivatives

J FOTIE, M KAISER, KA WERBOVETZ… - Journal of medicinal …, 2010 - pascal-francis.inist.fr
Antitrypanosomal Activity of 1,2-Dihydroquinolin-6-ols and Their Ester Derivatives CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Antitrypanosomal activity of 1, 2-dihydroquinolin-6-ols and their ester derivatives.

J Fotie, M Kaiser, DA Delfín, J Manley… - Journal of Medicinal …, 2010 - europepmc.org
The current chemotherapy for second stage human African trypanosomiasis is
unsatisfactory. A synthetic optimization study based on the lead antitrypanosomal compound …

[引用][C] Antitrypanosomal Activity of 1, 2-Dihydroquinolin-6-ols and Their Ester Derivatives

J Fotie, M Kaiser, DA Delfín, J Manley… - Journal of Medicinal …, 2010 - cir.nii.ac.jp
Antitrypanosomal Activity of 1,2-Dihydroquinolin-6-ols and Their Ester Derivatives | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Antitrypanosomal activity of 1, 2-dihydroquinolin-6-ols and their ester derivatives

J Fotie, M Kaiser, DA Delfin, J Manley… - Journal of Medicinal …, 2010 - hero.epa.gov
The current chemotherapy for second stage human African trypanosomiasis is
unsatisfactory. A synthetic optimization study based on the lead antitrypanosomal compound …

Antitrypanosomal activity of 1, 2-dihydroquinolin-6-ols and their ester derivatives

J Fotie, M Kaiser, DA Delfin… - … , DC, 1963, currens, 2010 - repository.uantwerpen.be
The current chemotherapy for second stage human African trypanosomiasis is
unsatisfactory. A synthetic optimization study based on the lead antitrypanosomal compound …

Antitrypanosomal activity of 1, 2-dihydroquinolin-6-ols and their ester derivatives

J Fotie, M Kaiser, DA Delfín… - Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
The current chemotherapy for second stage human African trypanosomiasis is
unsatisfactory. A synthetic optimization study based on the lead antitrypanosomal compound …

[引用][C] Antitrypanosomal Activity of 1, 2-Dihydroquinolin-6-ols and Their Ester Derivatives

J Fotie, M Kaiser, DA Delfín, J Manley, CS Reid… - Journal of Medicinal …, 2010 - infona.pl
Antitrypanosomal Activity of 1,2-Dihydroquinolin-6-ols and Their Ester Derivatives × Close
The Infona portal uses cookies, ie strings of text saved by a browser on the user's device. The …

Antitrypanosomal activity of 1, 2-dihydroquinolin-6-ols and their ester derivatives

J Fotie, M Kaiser, DA Delfin, J Manley… - Journal of medicinal …, 2010 - edoc.unibas.ch
The current chemotherapy for second stage human African trypanosomiasis is
unsatisfactory. A synthetic optimization study based on the lead antitrypanosomal compound …

Antitrypanosomal activity of 1, 2-dihydroquinolin-6-ols and their ester derivatives.

J Fotie, M Kaiser, DA Delfín, J Manley, CS Reid… - 2010 - cabidigitallibrary.org
The current chemotherapy for second stage human African trypanosomiasis is
unsatisfactory. A synthetic optimization study based on the lead antitrypanosomal compound …